{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:51:28Z","timestamp":1760709088679},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijcard.2016.06.014","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T01:28:07Z","timestamp":1466299687000},"page":"180-185","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era"],"prefix":"10.1016","volume":"219","author":[{"given":"Toshihito","family":"Onda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Okai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.014_bb0005","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/CIR.0000000000000134","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0010","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/oxfordjournals.eurheartj.a015461","volume":"18","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-199856010-00004","article-title":"Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?","volume":"56","author":"Boersma","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0020","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","article-title":"Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0030","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/clinchem\/43.8.1372","article-title":"Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction","volume":"43","author":"Ishii","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archinternmed.2008.563","article-title":"Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry","volume":"169","author":"Yan","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0045","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT investigators","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0050","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0055","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12262-012-0483-y","article-title":"Feasibility of rapid parathormone assay for enabling minimally invasive parathyroid excision","volume":"75","author":"Padma","year":"2013","journal-title":"Indian J. Surg."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1515\/CCLM.2008.188","article-title":"Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice","volume":"46","author":"Vittorini","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0070","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1253\/circj.CJ-11-0598","article-title":"Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain","volume":"75","author":"Inoue","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0075","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1253\/circj.CJ-13-0174","article-title":"Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry","volume":"77","author":"Daida","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0080","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0085","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","article-title":"Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study","volume":"31","author":"Tanizaki","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1253\/circj.CJ-09-0619","article-title":"MIYAGI-AMI study investigators. Trends in acute myocardial infarction incidence and mortality over 30years in Japan: report from the MIYAGI-AMI registry study","volume":"74","author":"Takii","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0095","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999\u20132006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal probrain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00231390","article-title":"Cellular fatty acid-binding proteins: current concepts and future directions","volume":"98","author":"Glatz","year":"1990","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0009-9120(91)90571-U","article-title":"Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction","volume":"24","author":"Tanaka","year":"1991","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01270583","article-title":"Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man","volume":"116","author":"Kleine","year":"1992","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0120","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/01.CIR.0000147611.92021.2B","article-title":"Platelet receptor inhibition in ischemic syndrome management (PRISM) investigators, N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes","volume":"110","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.014_bb0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijcard.2006.04.038","article-title":"Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty","volume":"115","author":"Grabowski","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2005.08.036","article-title":"Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)","volume":"97","author":"James","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.014_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-006-0457-9","article-title":"A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes","volume":"96","author":"Ndrepepa","year":"2007","journal-title":"Clin. Res. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T11:06:45Z","timestamp":1600772805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316310245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"alternative-id":["S0167527316310245"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.014","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}